Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia

Condition(s) studied

Investigational drug(s) / intervention(s)

Dietary modification: Patients will follow Mediterranean Diet (MD), this diet is characterized by a high intake of vegetables, fruit, whole cereals, legumes, nuts, and fish and a low intake of red meat and homemade desserts. The main added fat was extra virgin olive oil, with 35-40% kcal from fat (\<10% from saturated fat), 40-44% kcal from carbohydrate, and 20% kcal from protein

Supplementation of omega 3 fatty acids: Supplementation of omega 3 fatty acids ( dose based on weight: \<40 kg-450 mg/day, 40-60 kg-900 mg/day, \>60 kg-1300 mg/day)

Study summary

This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.

Eligibility

Primary outcome measure(s)

• Implementation a program of hepatic support — Almost 1 year
  To implement a hepatoprotection interventional program to children and adolescent with ALL during Total XV induction c

Trial sites (2)

More Ain Shams University trials in Egypt

Other trials for the same condition